Initiate Ventures’ Post

View organization page for Initiate Ventures, graphic
Initiate Ventures

3,786 followers

In a previous post, we overviewed the three sectors where we invest: Precision Medicine, Biopharma Tools & Technology, and Health Tech (link to that post here: https://lnkd.in/eEfkbAdE). Here, we share more on our thesis in diagnostic platforms that elucidate molecular mechanisms of disease biology. While the field of oncology diagnostics has experienced dramatic growth (and market correction) over the last five years, we have conviction in early stage companies that aim to apply successful oncology diagnostic playbooks to other large diseases, like auto-immune, cardiometobolic, and neurologic disease. Ingredients for good-fit Seed & Series A companies include: ✅ Category-defining science in population-scale diseases with robust drug pipelines and emerging therapeutic options ✅ Commercially oriented leadership with experience generating scientific and clinical evidence that drives partnerships, adoption, and reimbursement ✅ Platforms that combine computational and biologic methods to uncover molecular mechanisms of disease and help biopharma improve drug discovery and development ✅ A clinical product vision that aligns to the incentives of physicians, payers, and patients    ✅ A capital-efficient path to revenue Are you building an early stage company with these features? We’d love to connect and learn more. #precisionmedicine #biomarkers #diagnostics #healthcareinnovation #venturecapital

To view or add a comment, sign in

More Relevant Posts

Initiate Ventures

3,786 followers

View Profile

Explore topics